DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/lx6ckb/aids_related) has announced the addition of the "AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for AIDS - Related Kaposi's Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for AIDS - Related Kaposi's Sarcoma and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
- Aphios Corporation
- AstraZeneca Plc
- Biogenomics Limited
- CytRx Corporation
Drug Profiles
- aldoxorubicin hydrochloride
- CS-TATI-1
- interferon alfa-2a (recombinant)
- interferon alfa-2b (recombinant)
- paclitaxel nanosomal
- selumetinib sulfate
For more information visit http://www.researchandmarkets.com/research/lx6ckb/aids_related
